Mary Woolley Weekly Advocacy Messages
I am pleased to repeat myself when I report that it’s been another science-heavy week on Capitol Hill...and most, but not all, of the news is good.
The House Energy and Commerce Health subcommittee considered the next draft of the 21st Century Cures legislation this morning.
This Thanksgiving will be challenging – there is no way around it – but giving thanks right now is especially appropriate. Medical and public health personnel, academic and industry researchers, and a plethora of other COVID-19 responders have put the interests of the public ahead of their own, working in high-risk settings, 24-7, to navigate an end to this brutal pandemic. And end it, we will.
On Capitol Hill: Senate Republicans have a new legislative proposal for COVID-19 emergency supplemental spending which includes provisions such as extended unemployment benefits and emergency funding for USPS, but no supplemental funding to restore COVID-19-eroded research dollars.
Phase 3 enrollment is now underway for a number of COVID-19 vaccine clinical trials.
We lost two extraordinary Civil Rights heroes this past weekend, John Lewis and C.T. Vivian. Of these courageous, committed advocates, Dr. Louis Sullivan, former HHS Secretary, Research!America emeritus board member, and friend to research advocacy, said in a statement: “The lives of millions are better today because of their leadership and their sacrifice.”
On Tuesday, the Administration notified the United Nations of its intent to withdraw the U.S. from the World Health Organization (WHO)
Dear Research Advocate,
Mentioned here last week and the focus of an alliance member webinar earlier this week, the President issued an executive order (EO) extending and imposing new restrictions on worker and student visas.
Our nation’s research enterprise – and thus our society – has long benefitted mightily from the contributions of foreign-born scientists and engineers. In fact, nearly a third of the STEM workforce is foreign-born